Spondyloarthritis & psoriatic arthritis

Predicting disease flares in axial spondyloarthritis using different machine learning models in the METEOR-SpA registry

RMD OpenPublished Prognostic model development and external validation study

Authors' conclusion

A reduced logistic-regression model showed moderate internal and modest external discrimination for short-term flare risk in axSpA.

Study context

Population
Patients with axial spondyloarthritis (axSpA) receiving bDMARDs in the METEOR-SpA registry
Participants
1,167 patients3,865 visits
Comparison
Internal cross-validation (CV) vs GLAS
Outcome
Flare: ASDAS increase ≥0.9 (or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) increase ≥2) at the next 6-month assessment
Follow-up
Next 6-month assessment
Methodological detailsmachine learning, patient-grouped cross-validation, decision curve analysis
  • Machine learning
  • Patient-grouped cross-validation
  • Decision curve analysis

Performance

As reported in the abstract

Discrimination of the final ridge logistic regression model for flare at next 6-month assessment
Test or modelROC-AUC (95% CI)Average precision (AP)
Internal CV0.72 (0.70 to 0.75)0.291 (0.245 to 0.337)
GLAS0.63 (0.59 to 0.68)0.142 (0.116 to 0.171)

ROC-AUC (95% CI)

Internal CV0.72 (0.70 to 0.75)
GLAS0.63 (0.59 to 0.68)

Average precision (AP)

Internal CV0.291 (0.245 to 0.337)
GLAS0.142 (0.116 to 0.171)

Further findings

Patients with ≥1 flare, among 618 (52.9%) with ≥1 visit of known flare status

Experienced ≥1 flare
170 (27.5%)

Predictors retained in the final model

Eight predictors associated with flare: Axial Spondyloarthritis Disease Activity Score (ASDAS) (current and previous), female sex, flare history, enthesitis, infliximab exposure, PGA and CRP
8

Decision curve analysis

Modest positive net clinical benefit at low threshold probabilities

Original publication

Predicting disease flares in axial spondyloarthritis using different machine learning models in the METEOR-SpA registry. RMD Open. Published 24 September 2026. doi:10.1136/rmdopen-2026-007147

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.